Addinex Technologies, Inc., a healthcare technology company focused on the innovation of medication dispensing, has been awarded a $260K Phase I Small Business Innovation Research (SBIR) grant by the Centers for Disease Control and Prevention (CDC) to improve on existing addiction medication dispensing for people with opioid use disorder (OUD). Addinex will team up with Aware Recovery Care, the iHat Institute, and Yale University on the project.
The grant will help fund the adaptation of Addinex’s award-winning patented pill dispensing system that recently completed a successful study using opioids on post-surgical cancer patients at Columbia University Medical Center. Results of that study were recently published in the peer-reviewed journal, Cancer. The adapted dispenser will work with buprenorphine, including Suboxone®, a common form of addiction treatment medication that comes in a sublingual film. Addinex’s patient app will focus on the unique needs of people suffering from OUD.
“9.5 million people aged 12 or older misuse opioids representing 3.3% of that population, 2.7 million people suffer from OUD, and annual overdose deaths from opioids recently rose to over 80,000. Many patients diagnosed with OUD will be treated by a combination of buprenorphine, a schedule III narcotic, with counseling and behavioral therapies, also known as Medication Assisted Treatment,” stated Jay Schiff, Co-Founder and CEO of Addinex Technologies, Inc. “Our patented, low-cost medication dispensing system provides a cost-effective way to improve adherence and reduce diversion while educating patients about proper usage. We’re excited to work with a world-class team of addiction treatment providers and researchers.”
According to Shelley Halligan, SVP Medical Affairs, Aware Recovery Care, “This is the type of cutting-edge advancement needed in this space. Individuals with OUD recover better in the home, allowing for more autonomy and family involvement in the recovery journey. We are thrilled to partner with Addinex, Yale University, and the IHATI on this project.”